机译:通过选择性地耗尽G-MDSCs:一种新的化学杂交策略,Cisplatin抑制膀胱癌的进展
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Urol Shanghai Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Urol Shanghai Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Urol Shanghai Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Urol Shanghai Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Urol Shanghai Peoples R China;
Fudan Univ Hosp Obstet &
Gynecol Lab Reprod Immunol Shanghai Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Urol Shanghai Peoples R China;
Fudan Univ Hosp Obstet &
Gynecol Lab Reprod Immunol Shanghai Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Obstet &
Gynecol Shanghai Peoples R;
Shanghai Jiao Tong Univ Sch Med Shanghai Gen Hosp Dept Urol Shanghai Peoples R China;
Cisplatin; Bladder cancer; Myeloid-derived suppressor cells; CD8(+) T cells; Immunomodulation;
机译:通过选择性地耗尽G-MDSCS,顺铂抑制膀胱癌的进展:一种新的化学杂交策略
机译:选择性环氧合酶-2抑制剂JTE-522在体外和体内增强了膀胱癌细胞对顺铂介导的细胞毒性和凋亡的敏感性。
机译:设计的Crispr / Cas13d感应hettt在体外选择性地抑制膀胱癌的进展
机译:Sp〜2- ininoolugar n-,s-和c-糖苷作为中性α-葡糖苷酶的选择性抑制剂:在人乳腺癌细胞的进展中的作用
机译:miR-223双链体的双链(miR-223-5p和miR-223-3p)抑制癌细胞侵袭性:靶向基因参与膀胱癌的发病机理
机译:经尿道手术和每日两次放射联合紫杉醇-顺铂或氟尿嘧啶-顺铂联合选择性膀胱保存和辅助化学疗法治疗肌肉浸润性膀胱癌的患者(RTOG 0233):一项随机的多中心2期临床试验
机译:聚酰胺胺通过选择性地诱导线粒体DNA耗尽和功能障碍来抑制前列腺癌进展
机译:改善顺铂治疗肺癌的药物基因组学策略